Applied Genetic Technologies (AGTC) Misses Q1 EPS by 5c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of ($0.34), $0.05 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $705 million, versus $258 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Terreno Realty Corp (TRNO) PT Raised to $75 at KeyBanc on 'Improving Demand'
• Nebius soars on second quarter revenue beat